PURPOSE: To describe the clinical features and genetic analysis of eight X-linked congenital stationary night blindness (XLCSNB) Dutch patients. METHODS: Electroretinogram (ERG) measurements were assessed in Dutch patients. Molecular genetic testing by denaturing high performance liquid chromatography (DHPLC), single stranded conformation polymorphism (SSCP) analysis, and direct sequencing of the CACNA1F and NYX genes were performed in the patients possessing a negative Schubert Bornschein ERG. RESULTS: Molecular genetic testing of CACNA1F and NYX revealed three novel and two known CACNA1F sequence variants as well as two novel sequence alterations in the NYX gene. While one of the CACNA1F sequence variants (5756G>A, R1919H) has been previously described as a common polymorphism in Japanese families, we did not found this transition in 100 European control alleles. CONCLUSIONS: In a pool of eight diagnosed XLCSNB patients, five showed a sequence variation in the CACNA1F and two in the NYX gene. In only one of the eight patients no sequence alteration could be detected. This might be explained by a mutation in other, as yet unidentified coding or regulatory sequences of NYX or CACNA1F or additional genes.
PURPOSE: To describe the clinical features and genetic analysis of eight X-linked congenital stationary night blindness (XLCSNB) Dutch patients. METHODS: Electroretinogram (ERG) measurements were assessed in Dutch patients. Molecular genetic testing by denaturing high performance liquid chromatography (DHPLC), single stranded conformation polymorphism (SSCP) analysis, and direct sequencing of the CACNA1F and NYX genes were performed in the patients possessing a negative Schubert Bornschein ERG. RESULTS: Molecular genetic testing of CACNA1F and NYX revealed three novel and two known CACNA1F sequence variants as well as two novel sequence alterations in the NYX gene. While one of the CACNA1F sequence variants (5756G>A, R1919H) has been previously described as a common polymorphism in Japanese families, we did not found this transition in 100 European control alleles. CONCLUSIONS: In a pool of eight diagnosed XLCSNB patients, five showed a sequence variation in the CACNA1F and two in the NYX gene. In only one of the eight patients no sequence alteration could be detected. This might be explained by a mutation in other, as yet unidentified coding or regulatory sequences of NYX or CACNA1F or additional genes.
Authors: R Jalkanen; M Mäntyjärvi; R Tobias; J Isosomppi; E-M Sankila; T Alitalo; N T Bech-Hansen Journal: J Med Genet Date: 2006-02-27 Impact factor: 6.318
Authors: Christina Zeitz; Barbara Kloeckener-Gruissem; Ursula Forster; Susanne Kohl; István Magyar; Bernd Wissinger; Gábor Mátyás; François-Xavier Borruat; Daniel F Schorderet; Eberhart Zrenner; Francis L Munier; Wolfgang Berger Journal: Am J Hum Genet Date: 2006-08-23 Impact factor: 11.025
Authors: Bo Chang; John R Heckenlively; Philippa R Bayley; Nicholas C Brecha; Muriel T Davisson; Norm L Hawes; Arlene A Hirano; Ronald E Hurd; Akihiro Ikeda; Britt A Johnson; Maureen A McCall; Catherine W Morgans; Steve Nusinowitz; Neal S Peachey; Dennis S Rice; Kirstan A Vessey; Ronald G Gregg Journal: Vis Neurosci Date: 2006 Jan-Feb Impact factor: 3.241
Authors: Ronald G Gregg; Maarten Kamermans; Jan Klooster; Peter D Lukasiewicz; Neal S Peachey; Kirstan A Vessey; Maureen A McCall Journal: J Neurophysiol Date: 2007-09-19 Impact factor: 2.714
Authors: Maria M van Genderen; Mieke M C Bijveld; Yvonne B Claassen; Ralph J Florijn; Jillian N Pearring; Francoise M Meire; Maureen A McCall; Frans C C Riemslag; Ronald G Gregg; Arthur A B Bergen; Maarten Kamermans Journal: Am J Hum Genet Date: 2009-11-05 Impact factor: 11.025
Authors: Jan Klooster; Maria M van Genderen; Minzhong Yu; Ralph J Florijn; Frans C C Riemslag; Arthur A B Bergen; Ronald G Gregg; Neal S Peachey; Maarten Kamermans Journal: Invest Ophthalmol Vis Sci Date: 2013-10-23 Impact factor: 4.799